The top five tweets: From regional growth to drug affordability — what excited EPM readers this week?

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics.

5. In fifth place is the news that Acesion Pharma will start a Phase I study of its lead candidate to treat atrial fibrillation.

4. The affordability of Praluent for high-risk patients comes in fourth position this week.

3. The announcement that the House of Lords were questioning NHS England on the life sciences industrial strategy makes it onto the list at number three.

2. Runner up for the week is the news that BCI Pharma has received both public and private funding to accelerate research projects.

1. TraceLink’s growth in the DACH region of more than 200% is the top story for our list this week.